Onyx Biotec Ltd

AI

Onyx Biotec Ltd

₹ 36.0 -1.37%
28 Oct - close price
About

Incorporated in 2005, Onyx Biotech Ltd manufactures and sells Sterile Water for Injections, Dry Powder Injections and Dry
Syrup for India and overseas, through a
B2B business model[1]

Key Points

Business Overview:[1]
OBL is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. The company develops, manufactures and distributes generic and branded pharmaceutical products in various forms like (WFI) Water for Injection, Dry Powder Injections, Dry Powder Syrup.

  • Market Cap ₹ 65.3 Cr.
  • Current Price ₹ 36.0
  • High / Low ₹ 49.6 / 24.2
  • Stock P/E
  • Book Value ₹ 30.6
  • Dividend Yield 0.00 %
  • ROCE 1.15 %
  • ROE -0.38 %
  • Face Value ₹ 10.0

Pros

  • Stock is trading at 1.18 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -23.4%
  • Company has a low return on equity of 6.12% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
23.89 29.86 30.15 31.80 34.59 34.88
20.47 24.95 24.44 27.17 33.65 32.43
Operating Profit 3.42 4.91 5.71 4.63 0.94 2.45
OPM % 14.32% 16.44% 18.94% 14.56% 2.72% 7.02%
0.04 0.09 0.99 0.18 0.24 0.21
Interest 0.83 1.27 1.36 0.62 0.55 0.66
Depreciation 0.73 1.14 1.53 1.51 1.56 1.49
Profit before tax 1.90 2.59 3.81 2.68 -0.93 0.51
Tax % 15.26% 21.24% 21.52% 26.12% -3.23% -35.29%
1.60 2.03 2.99 1.97 -0.90 0.69
EPS in Rs 1.36 1.52 2.24 1.09 -0.50 0.38
Raw PDF
Upcoming result date: 14 November 2026

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
44.86 39.49 53.75 61.95 69.47
39.09 34.99 45.36 51.57 66.06
Operating Profit 5.77 4.50 8.39 10.38 3.41
OPM % 12.86% 11.40% 15.61% 16.76% 4.91%
0.12 0.11 0.13 1.17 0.44
Interest 0.65 0.57 2.16 2.02 1.22
Depreciation 1.45 1.49 1.87 3.05 3.05
Profit before tax 3.79 2.55 4.49 6.48 -0.42
Tax % 11.61% 27.45% 19.15% 23.46% -50.00%
3.35 1.84 3.63 4.95 -0.21
EPS in Rs 2.84 1.56 2.72 2.73 -0.12
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -106%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -10%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 6%
Last Year: 0%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5.90 5.90 13.32 18.13 18.13
Reserves 10.47 12.30 11.97 37.49 37.28
12.25 29.23 30.78 12.46 15.17
8.22 11.30 18.07 23.17 24.58
Total Liabilities 36.84 58.73 74.14 91.25 95.16
17.23 42.50 43.48 40.90 39.16
CWIP 4.02 0.00 0.00 0.00 3.68
Investments 0.00 0.00 0.00 0.00 0.00
15.59 16.23 30.66 50.35 52.32
Total Assets 36.84 58.73 74.14 91.25 95.16

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.49 1.96 1.52 1.42 -1.49
-5.78 -22.68 -3.15 0.66 -4.58
5.20 16.43 3.09 5.07 1.50
Net Cash Flow -0.09 -4.30 1.46 7.15 -4.57
Free Cash Flow -5.30 -20.78 -1.70 1.91 -6.48
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 8% 44% 18% 14% -44%

Ratios

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 68.51 46.95 104.37 119.19 144.49
Inventory Days 41.98 109.92 92.94 150.14 99.20
Days Payable 59.46 120.16 140.83 156.02 124.70
Cash Conversion Cycle 51.03 36.71 56.48 113.32 118.98
Working Capital Days 35.72 -52.22 37.62 87.49 77.29
ROCE % 8.23% 12.85% 12.16% 1.15%

Insights

In beta
Mar 2024 Mar 2025 Mar 2026
Employee Benefits Expense
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees
count
Production Machines (Unit-1 SWFI)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Nov 2024Mar 2025Sep 2025Mar 2026Sep 2026
65.10% 65.10% 65.10% 65.10% 41.74%
8.72% 5.36% 1.95% 1.07% 0.22%
3.29% 2.39% 2.39% 2.39% 2.39%
22.89% 27.15% 30.56% 31.44% 55.64%
No. of Shareholders 1,181551640586631

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents